# The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study

> **NCT00489112** · PHASE4 · UNKNOWN · sponsor: **HaEmek Medical Center, Israel**

## Conditions studied

- Distal Ureterolithiasis

## Interventions

- **DRUG:** Alfuzocine XL 10 mg once a day

## Key facts

- **NCT ID:** NCT00489112
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489112, "The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00489112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*